We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.15B
AUM Growth
+$59M
Cap. Flow
-$87.2M
Cap. Flow %
-7.58%
Top 10 Hldgs %
12.78%
Holding
1,132
New
384
Increased
172
Reduced
194
Closed
306

Top Buys

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$12.8M
2
JIH.U
Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00
JIH.U
+$9.53M
3
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
+$8.79M
4
AMZN icon
Amazon
AMZN
+$6.74M
5
BABA icon
Alibaba
BABA
+$6.59M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15.9M
2
CELG
Celgene Corp
CELG
+$15M
3
AABA
Altaba Inc
AABA
+$10.1M
4
BMTX
BM Technologies, Inc.
BMTX
+$9.25M
5
GCMG icon
GCM Grosvenor
GCMG
+$8.1M

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Healthcare 10.04%
3 Consumer Discretionary 6.7%
4 Real Estate 4.77%
5 Communication Services 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBRL icon
476
Cracker Barrel
CBRL
$1.26B
$508K 0.04%
+3,302
New +$520K
ACOR
477
DELISTED
Acorda Therapeutics
ACOR
$504K 0.04%
+2,058
New +$519K
AMHCU
478
DELISTED
Amplitude Healthcare Acquisition Corporation Unit
AMHCU
$504K 0.04%
+50,000
New +$501K
AVTR icon
479
Avantor
AVTR
$9.32B
$503K 0.04%
27,702
-15,071
-35% -$240K
HARP
480
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$503K 0.04%
+3,400
New +$516K
STM icon
481
STMicroelectronics
STM
$46.7B
$498K 0.04%
+18,519
New +$438K
BN icon
482
Brookfield
BN
$104B
$496K 0.04%
24,047
– –
KNSA icon
483
Kiniksa Pharmaceuticals
KNSA
$5.8B
$487K 0.04%
+44,000
New +$382K
BIOX.WS
484
DELISTED
Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares
BIOX.WS
$486K 0.04%
96,160
– –
LYFT icon
485
Lyft
LYFT
$6.02B
$485K 0.04%
11,279
+4,201
+59% +$184K
ARQL
486
DELISTED
Arqule Inc
ARQL
$485K 0.04%
24,314
-103,993
-81% -$1.21M
BOLD
487
DELISTED
Audentes Therapeutics, Inc
BOLD
$485K 0.04%
+8,100
New +$304K
ANAB icon
488
AnaptysBio
ANAB
$1.58B
$484K 0.04%
+29,775
New +$704K
ECOL
489
DELISTED
US Ecology, Inc.
ECOL
$484K 0.04%
+8,353
New +$495K
AQST icon
490
Aquestive Therapeutics
AQST
$463M
$483K 0.04%
+83,009
New +$432K
AERI
491
DELISTED
Aerie Pharmaceuticals
AERI
$483K 0.04%
20,000
+7,451
+59% +$154K
CVM.WS
492
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$480K 0.04%
525
– –
EXTN
493
DELISTED
Exterran Corporation
EXTN
$479K 0.04%
61,235
-48,402
-44% -$449K
SRE icon
494
Sempra
SRE
$57.9B
$477K 0.04%
+6,296
New +$462K
GLNG icon
495
Golar LNG
GLNG
$5B
$476K 0.04%
33,463
+41
+0.1% +$556
CAT icon
496
CALL
Caterpillar
CAT
$375B
$473K 0.04%
+32
New +$4.47K
FTACW
497
DELISTED
FinTech Acquisition Corp. III Warrant
FTACW
$471K 0.04%
+46,511
New +$62.7K
PBYI icon
498
Puma Biotechnology
PBYI
$404M
$466K 0.04%
53,289
-11,243
-17% -$93.1K
AXSM icon
499
PUT
Axsome Therapeutics
AXSM
$11.2B
$465K 0.04%
+45
New +$1.82K
FIX icon
500
Comfort Systems
FIX
$60.9B
$461K 0.04%
9,249
-7,493
-45% -$364K
18 19
20
21 22

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Boothbay Fund Management held 1,132 positions worth $1.15B, up 5.4% from $1.09B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $87.2M in Q4 2019, closing 306 positions and reducing 194 holdings. Its most notable exit was Celgene Corp, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00 worth $9.4M.

  • Boothbay Fund Management's largest Q4 2019 buy was Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00: 949,000 shares worth $9.4M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q4 2019, an estimated $12.8M increase.
  • Boothbay Fund Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $15.9M.
  • Boothbay Fund Management fully exited Celgene Corp in Q4 2019, selling an estimated $15M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $1.15B portfolio in Q4 2019.
  • Boothbay Fund Management opened 384 new positions and closed 306 in Q4 2019.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $1.15B.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.